Đang chuẩn bị liên kết để tải về tài liệu:
Gene expression profiling in ischemic postconditioning to alleviate mouse liver ischemia/reperfusion injury

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Ischemic postconditioning (IPO) attenuates hepatic ischemia/reperfusion (I/R) injury. However, little is known about the underlying biological pathophysiology, which could be, at least in part, informed by exploring the transcriptomic changes using next-generation RNA sequencing (RNA-Seq). | Gene expression profiling in ischemic postconditioning to alleviate mouse liver ischemia/reperfusion injury

TÀI LIỆU LIÊN QUAN

Global assessment of organ specific basal gene expression over a diurnal cycle with analyses of gene copies exhibiting cyclic expression patterns

NexGenEx-Tom: A gene expression platform to investigate the functionalities of the tomato genome

Expression profiling of resistance gene analogs from French bean (Phaseolus vulgaris L.) for the manifestation of moong bean yellow mosaic virus

Quantitative trait loci identification, fine mapping and gene expression profiling for ovicidal response to whitebacked planthopper (Sogatella furcifera Horvath) in rice (Oryza sativa L.)

Global gene expression profiling identifies ALDH2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinoma

Potential cancer-related role of circadian gene TIMELESS suggested by expression profiling and in vitro analyses

Gene expression profiling of adp glucose pyrophosphorylase ((AGPase) in sink and source organs of some cassava varieties with different starch contents in Vietnam

Gene expression profiling analysis of CRTC1- MAML2 fusion oncogene-induced transcriptional program in human mucoepidermoid carcinoma cells

Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression

Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia – identification of responders by gene expression profiling of pretreatment leukemic cells